Hytrin: Effective Blood Pressure and BPH Management
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.74 | $73.53 $66.22 (10%) | 🛒 Add to cart |
| 120 | $0.70 | $98.04 $84.28 (14%) | 🛒 Add to cart |
| 180 | $0.65 | $147.06 $117.82 (20%) | 🛒 Add to cart |
| 270 | $0.63 | $220.59 $170.28 (23%) | 🛒 Add to cart |
| 360 | $0.62
Best per pill | $294.12 $223.60 (24%) | 🛒 Add to cart |
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.09 | $62.78 (0%) | 🛒 Add to cart |
| 60 | $1.63 | $125.56 $98.04 (22%) | 🛒 Add to cart |
| 90 | $1.48 | $188.34 $133.30 (29%) | 🛒 Add to cart |
| 120 | $1.40 | $251.12 $168.56 (33%) | 🛒 Add to cart |
| 180 | $1.33 | $376.68 $239.08 (37%) | 🛒 Add to cart |
| 270 | $1.28
Best per pill | $565.02 $346.58 (39%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.55 | $76.54 (0%) | 🛒 Add to cart |
| 60 | $1.92 | $153.08 $115.24 (25%) | 🛒 Add to cart |
| 90 | $1.71 | $229.62 $153.94 (33%) | 🛒 Add to cart |
| 120 | $1.61 | $306.16 $193.50 (37%) | 🛒 Add to cart |
| 180 | $1.50 | $459.24 $270.90 (41%) | 🛒 Add to cart |
| 270 | $1.44
Best per pill | $688.86 $387.86 (44%) | 🛒 Add to cart |
Synonyms
| |||
Hytrin (terazosin hydrochloride) is a selective alpha-1 adrenergic receptor blocker indicated for the treatment of hypertension (high blood pressure) and the signs and symptoms of benign prostatic hyperplasia (BPH). As a first-line therapeutic option, it functions by relaxing blood vessels and the smooth muscle of the prostate and bladder neck, facilitating improved blood flow and urinary symptoms. Its well-established efficacy and favorable pharmacokinetic profile make it a cornerstone in managing these common conditions under appropriate medical supervision.
Features
- Active Pharmaceutical Ingredient: Terazosin Hydrochloride
- Available in tablet formulations: 1 mg, 2 mg, 5 mg, 10 mg
- Selective antagonist of postsynaptic alpha-1 adrenergic receptors
- Exhibits a long half-life, allowing for once-daily dosing in maintenance therapy
- Demonstrated efficacy in reducing both systolic and diastolic blood pressure
- Proven to improve urinary flow rates and reduce symptoms of BPH (e.g., hesitancy, weak stream, nocturia)
Benefits
- Dual Therapeutic Action: Effectively manages two distinct conditions—hypertension and BPH—with a single agent, simplifying treatment regimens for appropriate patients.
- Improved Urinary Function: Provides significant relief from obstructive and irritative symptoms associated with an enlarged prostate, enhancing quality of life by reducing nocturia and improving bladder emptying.
- Effective Blood Pressure Control: Promotes vasodilation, leading to a reduction in peripheral vascular resistance and consequently lowering elevated blood pressure, thereby mitigating long-term cardiovascular risks.
- Convenient Dosing Schedule: Its extended duration of action supports a once-daily dosing schedule for maintenance, improving patient adherence to the prescribed therapy.
- Rapid Onset for BPH: Patients often experience symptomatic improvement in urinary flow within two weeks of initiating therapy.
Common use
Hytrin is primarily prescribed for the management of essential hypertension. It can be used alone or concomitantly with other antihypertensive agents, such as diuretics or beta-blockers, for additive blood pressure control. Its second primary indication is for the treatment of symptomatic benign prostatic hyperplasia (BPH). It is used to alleviate symptoms like urinary hesitancy, weak stream, dribbling, and nocturia. Treatment is intended for symptomatic relief and does not reduce the size of the prostate or prevent the need for surgery in the future.
Dosage and direction
For Hypertension: The initial dose is 1 mg at bedtime. This initial dosing regimen is mandatory to minimize the risk of a pronounced first-dose effect (e.g., syncope). The dose should then be slowly titrated upward based on individual patient response. The usual recommended dosage range is 1 mg to 5 mg administered once daily; some patients may benefit from doses up to 20 mg per day. Doses may be divided if necessary.
For Benign Prostatic Hyperplasia: The initial dose is also 1 mg at bedtime. Subsequent doses should be increased in a step-wise fashion to 2 mg, 5 mg, or 10 mg once daily to achieve optimal improvement in symptoms and urinary flow rates. The recommended maintenance dose is 10 mg once daily for most patients. Doses greater than 20 mg do not appear to provide further efficacy.
Administration: Tablets can be taken with or without food. The same initial dosing and titration schedule must be followed for both indications to avoid severe hypotension.
Precautions
- First-Dose Effect: A marked decrease in blood pressure with syncope (fainting) can occur 30 to 90 minutes after the initial dose or any subsequent rapid dose increase. This risk is minimized by initiating therapy at the 1 mg dose at bedtime.
- Orthostatic Hypotension: Patients should be cautioned about the potential for dizziness, lightheadedness, or fainting, particularly when rising from a sitting or lying position. This is more common during initiation and titration.
- Intraoperative Floppy Iris Syndrome (IFIS): This alpha-1 blocker class effect has been observed during cataract surgery. Ophthalmologists must be informed of the patient’s current or past use of terazosin prior to surgery.
- Priapism: Rare instances of painful or prolonged erections (lasting more than 4 hours) have been reported. This condition requires immediate medical attention to prevent permanent damage.
- Drowsiness/Somnolence: Patients should exercise caution when driving, operating machinery, or performing hazardous tasks until their response to the drug is known.
Contraindications
Hytrin is contraindicated in patients with a known hypersensitivity to terazosin hydrochloride, any other quinazolines (e.g., doxazosin, prazosin), or any component of the formulation.
Possible side effect
Common side effects are often related to its pharmacological action (vasodilation) and are usually most pronounced after the first dose or during dose titration. They often diminish with continued therapy.
- Very Common (>10%): Dizziness, headache, asthenia (lack of energy)
- Common (1-10%): Postural dizziness, palpitations, nausea, peripheral edema, somnolence (drowsiness), nasal congestion, blurred vision, vertigo
- Uncommon (0.1-1%): Syncope (fainting), weight gain, dyspnea (shortness of breath), impotence, priapism
- Rare (<0.1%): Intraoperative Floppy Iris Syndrome (IFIS)
Drug interaction
- Other Antihypertensives: Concomitant use with other blood pressure-lowering drugs (e.g., beta-blockers, ACE inhibitors, calcium channel blockers, diuretics) or phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil) may potentiate the hypotensive effects and increase the risk of syncope and orthostasis.
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Drugs like ibuprofen or naproxen may attenuate the antihypertensive effect of Hytrin by causing fluid retention and vasoconstriction.
- Estrogens: May reduce the antihypertensive efficacy of terazosin due to potential fluid-retentive properties.
- Beta-Blockers: The combination is common for hypertension but may increase the risk of first-dose hypotension, especially with concurrent diuretic use.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the missed dose should be skipped. The patient should not take a double dose to make up for the missed one. Maintaining the consistent bedtime schedule is important to manage the risk of orthostatic effects during the day.
Overdose
An overdose would be expected to manifest as exaggerated pharmacological effects, primarily severe hypotension, culminating in cardiovascular collapse and shock. Drowsiness, depressed reflexes, and a stuporous state may also occur. Treatment involves immediate cardiovascular support. The patient should be placed in a supine position, with legs elevated, to help restore blood pressure and brain perfusion. If necessary, vasopressor agents may be administered. Gastric lavage or induced emesis may be considered if ingestion was recent. As terazosin is highly protein-bound, dialysis is not likely to be of benefit.
Storage
Store Hytrin tablets at a controlled room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The medication must be kept in its original container, tightly closed, and protected from light and moisture. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or altering any treatment regimen. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has not been evaluated by all regulatory agencies and is intended for an expert audience.
Reviews
- Clinical Efficacy (Urologist’s Perspective): “In my practice, terazosin remains a reliable first-line option for managing moderate BPH symptoms. The titration protocol is straightforward, and a significant majority of patients report a noticeable improvement in urinary flow and reduction in nocturia within the first month. The once-daily dosing aids significantly with long-term compliance.”
- Patient Experience (Long-term User): “I’ve been on Hytrin for my blood pressure for over three years. The first week was a bit dizzying, but that passed. It has kept my numbers consistently in the normal range with a single pill at night. The convenience is a major plus.”
- Clinical Efficacy (Cardiologist’s Perspective): “As part of a combination therapy regimen for resistant hypertension, terazosin provides an effective mechanism for reducing peripheral resistance. Its side effect profile is well-understood, and with proper patient education on the initial dosing, it is a safe and valuable tool.”
- Patient Experience (BPH Treatment): “The difference in getting through the night without multiple trips to the bathroom was life-changing. The initial dizziness was a minor inconvenience for the benefit gained. It doesn’t cure the problem, but it makes it much more manageable day-to-day.”